Biorce, a Barcelona-based startup, has successfully closed a €43.8 million Series A funding round. The new capital will be used to accelerate the development of its AI-driven platform for clinical trials. The funding will help the company meet the increasing regulatory demands in healthcare. Biorce aims to enhance trial processes while ensuring compliance with strict documentation and transparency requirements.
Company Information
Company
Biorce
Location
Barcelona, Catalonia, Spain
About
Biorce is a Barcelona-based healthtech startup that leverages AI to address inefficiencies in clinical trials. Its platform, Jarvis, streamlines processes such as patient recruitment and trial protocol design, aiming to reduce delays and improve outcomes for patients. The company focuses on accelerating drug development and making clinical trials faster and more accessible. Biorce's technology is being adopted by leading pharmaceutical companies, biotechs, and CROs across various therapeutic areas.
Don't miss Biorce's next move
Get an email the moment Biorce raises, hires an exec, or expands, usually minutes after it happens.